🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/12/2011 4,20 4,26 4,08 4,20 -1,41% 4,29% 75.350
06/12/2011 4,26 4,44 4,20 4,26 +0,00% 5,63% 102.417
05/12/2011 4,26 4,26 4,14 4,26 +2,90% 2,82% 98.717
02/12/2011 4,20 4,38 4,14 4,14 +1,47% 5,71% 86.300
01/12/2011 4,26 4,44 4,02 4,08 -6,85% 9,86% 83.483
30/11/2011 4,44 4,44 4,08 4,38 +4,29% 8,11% 135.350
29/11/2011 4,38 4,50 4,20 4,20 -2,78% 6,85% 77.267
28/11/2011 4,20 4,44 4,20 4,32 +5,88% 5,71% 102.217
25/11/2011 4,20 4,32 4,08 4,08 -2,86% 5,71% 38.950
23/11/2011 4,74 4,74 4,14 4,20 -9,09% 12,66% 107.733
22/11/2011 4,74 5,04 4,62 4,62 -2,53% 8,86% 81.867
21/11/2011 4,80 5,10 4,62 4,74 -2,47% 10,00% 128.717
18/11/2011 5,04 5,28 4,74 4,86 -4,71% 10,71% 134.083
17/11/2011 5,28 5,40 5,04 5,10 -3,41% 6,82% 95.700
16/11/2011 5,16 5,46 5,16 5,28 +1,15% 5,81% 99.133
15/11/2011 4,92 5,28 4,92 5,22 +8,75% 7,32% 103.217
14/11/2011 4,98 5,16 4,74 4,80 -5,88% 8,43% 76.267
11/11/2011 5,16 5,16 4,92 5,10 +0,00% 4,65% 66.933
10/11/2011 5,04 5,10 4,92 5,10 +2,41% 3,57% 75.633
09/11/2011 5,22 5,40 4,86 4,98 -6,74% 10,34% 123.933
08/11/2011 5,34 5,52 5,28 5,34 +1,14% 4,49% 108.783
07/11/2011 5,40 5,52 5,28 5,28 -2,22% 4,44% 81.267
04/11/2011 6,00 6,00 5,10 5,40 -8,16% 15,00% 115.017
03/11/2011 5,82 5,88 5,64 5,88 +2,08% 4,12% 71.167
02/11/2011 5,82 5,88 5,58 5,76 +4,35% 5,15% 67.800
01/11/2011 5,64 5,82 5,46 5,52 -6,12% 6,38% 87.000
31/10/2011 6,06 6,12 5,82 5,88 -2,97% 4,95% 78.583
28/10/2011 6,12 6,12 5,94 6,06 -1,94% 2,94% 97.133
27/10/2011 5,88 6,18 5,70 6,18 +8,42% 8,16% 181.767
26/10/2011 5,88 5,88 5,52 5,70 +2,15% 6,12% 83.650